Target
Fatty acid-binding protein, intestinal
Ligand
BDBM22971
Substrate
n/a
Meas. Tech.
ChEMBL_555397 (CHEMBL964794)
Ki
8900±n/a nM
Citation
 Chuang, SVelkov, THorne, JPorter, CJScanlon, MJ Characterization of the drug binding specificity of rat liver fatty acid binding protein. J Med Chem 51:3755-64 (2008) [PubMed]  Article 
Target
Name:
Fatty acid-binding protein, intestinal
Synonyms:
FABP2 | FABPI | FABPI_HUMAN | Fatty acid binding protein intestinal | Fatty acid-binding protein, intestinal | I-FABP | Intestinal fatty acid-binding protein (hIFABP)
Type:
Protein
Mol. Mass.:
15207.56
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
132
Sequence:
MAFDSTWKVDRSENYDKFMEKMGVNIVKRKLAAHDNLKLTITQEGNKFTVKESSAFRNIEVVFELGVTFNYNLADGTELRGTWSLEGNKLIGKFKRTDNGNELNTVREIIGDELVQTYVYEGVEAKRIFKKD
  
Inhibitor
Name:
BDBM22971
Synonyms:
2-[(2,6-dichloro-3-methylphenyl)amino]benzoic acid | CHEMBL509 | Meclofenamate | Meclofenamic acid | US11337935, Compound Meclofenamic-acid | US20240002326, Compound Meclofenamic acid
Type:
Small organic molecule
Emp. Form.:
C14H11Cl2NO2
Mol. Mass.:
296.149
SMILES:
Cc1ccc(Cl)c(Nc2ccccc2C(O)=O)c1Cl
Structure:
Search PDB for entries with ligand similarity: